Breck Duerkop

Title: Breck Duerkop: Innovator in Bactobolin Analog Research

Introduction

Breck Duerkop is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel compounds. His work focuses on the synthesis and application of bactobolin analogs, which have potential implications in various scientific domains.

Latest Patents

Duerkop holds a patent for a bactobolin analog and its synthesis method. The patent describes a novel bactobolin analog, specifically bactobolin D. The invention outlines a method for producing a composition that includes at least one bactobolin analog using a bacterial strain that possesses the biosynthetic locus of the bactobolin analog, known as the bta cluster. This method also involves the isolation and purification of the bactobolin analog. The bacterial strains mentioned in the patent include wild type strains such as E264, Bt4, and TXDOH, as well as K96243, 1106a, and 1106b.

Career Highlights

Throughout his career, Breck Duerkop has worked with prestigious institutions, including the University of Washington and Harvard College. His research has contributed to advancements in the understanding and application of bacterial biosynthesis.

Collaborations

Duerkop has collaborated with notable colleagues such as E Peter Greenberg and Josephine R Chandler. These partnerships have enhanced his research and broadened the impact of his innovations.

Conclusion

Breck Duerkop is a distinguished inventor whose work on bactobolin analogs showcases his expertise in biotechnology. His contributions continue to influence the field and pave the way for future innovations.